RHBDF2 stabilizes SEC62 to sustain MDR1 biosynthesis and chemoresistance in breast cancer.

Song Y, Wang L, Liu Y, Ren T, Feng J, Cao X, Li L, Zhang Z

DOI: 10.20892/j.issn.2095-3941.2026.0488
Published: 2026 Oct 26
Container: Cancer biology & medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.20892/j.issn.2095-3941.2026.0488,
  title = {RHBDF2 stabilizes SEC62 to sustain MDR1 biosynthesis and chemoresistance in breast cancer.},
  author = {Song Y and Wang L and Liu Y and Ren T and Feng J and Cao X and Li L and Zhang Z},
  year = {2026},
  journal = {Cancer biology \& medicine},
  doi = {10.20892/j.issn.2095-3941.2026.0488},
  url = {https://doi.org/10.20892/j.issn.2095-3941.2026.0488}
}

RIS

TY  - JOUR
TI  - RHBDF2 stabilizes SEC62 to sustain MDR1 biosynthesis and chemoresistance in breast cancer.
AU  - Song Y
AU  - Wang L
AU  - Liu Y
AU  - Ren T
AU  - Feng J
AU  - Cao X
AU  - Li L
AU  - Zhang Z
PY  - 2026
JO  - Cancer biology & medicine
DO  - 10.20892/j.issn.2095-3941.2026.0488
UR  - https://doi.org/10.20892/j.issn.2095-3941.2026.0488
ER  -

APA

Y, S., L, W., Y, L., T, R., J, F., X, C., L, L., & Z, Z. (2026). RHBDF2 stabilizes SEC62 to sustain MDR1 biosynthesis and chemoresistance in breast cancer.. Cancer biology & medicine. https://doi.org/10.20892/j.issn.2095-3941.2026.0488

Source records

pubmed · retrieved 2026-11-10T14:37:50.975Z